Lupin acquires injectables firm I'rom Pharmaceuticals in Japan
This article was originally published in Scrip
Executive Summary
Lupin continues to make niche buys internationally, this time acquiring the Toyko-based specialty injectables firm, I’rom Pharmaceutical Co, for an undisclosed sum.